NCT06621355

Brief Summary

Muscle haemodynamics has so far been assessed using at most 2-3 near-infrared spectroscopy devices on isolated muscles and without correlating variables. At the same time, research on musculoskeletal pathologies is limited, and there are no studies that analyse the haemodynamic changes that occur when the anterior cruciate ligament (ACL) is injured and whether these changes last over time. The aim of the study is to monitor and evaluate the physiological changes produced by ACL injury on muscle performance using non-invasive near-infrared spectroscopy (NIRS) devices in trained athletes. This descriptive cross-sectional observational multicentre multicentre study, with Balearic Islands ethics committee IB 5585/24PI, will include males aged 18-65 years who have undergone ACL surgery, divided into 3 groups that: have an evolution of less than 6 months (ACL1), more than 2 years since the surgical intervention and are already practising normal physical-sports activities (ACL2) and the control group (CON) that has never suffered an ACL affectation to date. The 3 groups will perform an incremental intervallic test (4:1) on a cycloergometer or treadmill (according to the specificity of their sport), where different muscular haemodynamic variables will be assessed using 12-24 NIRS devices. The main study variables will be the muscular haemodynamic values of each muscle analysed and their correlation between them: muscular oxygen saturation, absolute capillary haemoglobin, loaded and unloaded with oxygen and relative muscular haemoglobin blood flow, loaded and unloaded with oxygen. Secondary variables will be heart rate, socio-demographic variables (age, toxic habits, injury and sports history) and subjective perception of effort (RPE-20).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
129

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Dec 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

September 25, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

December 2, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2026

Expected
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

12 months

First QC Date

September 25, 2024

Last Update Submit

September 27, 2024

Conditions

Keywords

Spectroscopy, Near-InfraredHemodynamicsExerciseVascular resistanceOxygen consumption

Outcome Measures

Primary Outcomes (7)

  • Muscular Oxygen Saturation (SmO2 - %)

    Percentage of haemoglobin + myoglobin at muscle capillary level loaded with oxygen

    From the start of the test up to 3 minutes after the end of the test

  • Absolute Capillary Haemoglobin (ThB - g/dL)

    grams of haemoglobin + myoglobin loaded and unloaded with oxygen divided by decilitres of blood taken up by the devices in the muscle capillaries

    From the start of the test up to 3 minutes after the end of the test

  • Oxygen-loaded capillary haemoglobin (O2HHb - g/dL)

    grams of haemoglobin + oxygen-loaded myoglobin divided by the decilitres of blood taken up by the devices in the muscle capillaries

    From the start of the test up to 3 minutes after the end of the test

  • Capillary Haemoglobin Oxygen Depleted (HHb - g/dL)

    grams of haemoglobin + oxygen-loaded myoglobin divided by the decilitres of blood taken up by the devices in the muscle capillaries

    From the start of the test up to 3 minutes after the end of the test

  • Blood Flow of Relative Muscle Haemoglobin (ThBBF - g/dL/min)

    relative value of haemoglobin blood flow per unit time circulating in the muscle capillary when heart rate values are added.

    From the start of the test up to 3 minutes after the end of the test

  • Blood Flow of Oxygen Loaded Relative Muscle Haemoglobin (O2HHbBF - g/dL/min)

    Relative value of oxygen-loaded haemoglobin blood flow per unit time circulating in the muscle capillary when heart rate values are added.

    From the start of the test up to 3 minutes after the end of the test

  • Blood Flow of Oxygen Discharged Relative Muscle Haemoglobin (HHbBF - g/dL/min)

    Relative value of the blood flow of oxygen discharged haemoglobin per unit time circulating in the muscle capillary when heart rate values are added.

    From the start of the test up to 3 minutes after the end of the test

Secondary Outcomes (6)

  • Heart Rate (ppm)

    From the start of the test up to 3 minutes after the end of the test

  • Subjective perception of effort (RPE-20)

    From the start of the test up to 3 minutes after the end of the test. At the end of each quarter minute of test work, during the one minute rest period, the patient will be asked his or her RPE.

  • Anthropometry and adiposity indicators: height

    The following variables will only be recorded once, at the beginning of the study, mainly to check that the eligibility criteria are met and to determine at a descriptive statistical level the normality and homogeneity of the sample.

  • Anthropometry and adiposity indicators: weight

    The following variables will only be recorded once, at the beginning of the study, mainly to check that the eligibility criteria are met and to determine at a descriptive statistical level the normality and homogeneity of the sample.

  • Anthropometry and adiposity indicators: skinfolds

    The following variables will only be recorded once, at the beginning of the study, mainly to check that the eligibility criteria are met and to determine at a descriptive statistical level the normality and homogeneity of the sample.

  • +1 more secondary outcomes

Study Arms (3)

LCA1

Patients with ACL involvement (with less than 6 months of evolution since the surgical intervention (IQ)) and are in a phase in which they can perform the incremental intervallic test either on a cycloergometer or treadmill.

Other: Physical fitness test: Progressive intervalic test

LCA2

Patients who have recovered from an ACL injury for more than 2 years. And can perform the incremental intervallic test either on a cycloergometer or treadmill.

Other: Physical fitness test: Progressive intervalic test

CON

Patients who have never suffered an ACL injury or involvement to date. And can also perform the test.

Other: Physical fitness test: Progressive intervalic test

Interventions

An incremental interval test of 4\' of work for 1\' of rest will be performed at an individual intensity below the aerobic threshold. At the end of the rest minute, the load shall be increased slightly. In order to be as adjusted and individualised as possible, the subjective physical condition level stated by the patient during the sociodemographic data collection shall be taken as a reference for the establishment of the initial load, being a value of power (W) in cycle ergometer and speed (km/h) in treadmill. Never less than 50W or 6 km/h, respectively. The minimum incremental values will be 25W or 0.5km/h until you are unable to complete a full interval. An incomplete interval shall also be recorded and analysed. During the one minute rest period, as will have been well emphasised during the explanation of the test, no part of the body may be moved at all, so at the end of the 4 minutes of work, the evaluator will count down for the patient to get ready and remain stil

Also known as: Physical fitness test
CONLCA1LCA2

Eligibility Criteria

Age18 Years - 65 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The sample, which will be selected by convenience, will be made up of participants who have a diagnosis of ACL involvement and who have undergone surgery (total or partial), either recently or have had an injury in previous years, may be recruited to participate in the study. Healthy, physically active patients who have never had an ACL injury will also be recruited. The sample will initially come from the Físic Espai de Salut Integral, Centre Re3MOVE, MET Salut, Hospital Universitari Son Espases (HUSE) and San Juan de Déu Palma-Inca centres. Other private and public physiotherapy, rehabilitation and recovery centres, as well as private entities (clubs, federations, associations and organisations) that may contain participants susceptible to being included in the study, are expected to be included as they are accepted by the respective research commissions.

You may qualify if:

  • Men aged 18 to 65
  • An adipose layer of \<2 cm in areas of NIRS placement, assessed with a plicometer
  • Understand written, read and spoken Spanish, English or Catalan.

You may not qualify if:

  • Having any cardio-metabolic, hormonal, neurological or other comorbidities that could affect participation in the study (e.g. severe mental illness, end-stage disease).
  • Eligibility criteria (LCA1 group)
  • Regular athlete with training and/or competition \>3 days/wk prior to injury.
  • ACL injury \<6 months after surgery.
  • Able to perform an incremental intervallic test on a cycloergometer or treadmill.
  • Eligibility criteria (LCA2 group)
  • Regular athlete with training and/or competition \>3 days a week.
  • ACL injury \>2 years after surgery.
  • Able to perform an incremental intervallic test on a cycloergometer or treadmill.
  • Eligibility criteria (CON group)
  • Regular athlete with training and/or competition \>3 days a week.
  • Never suffered an ACL injury in any knee - Able to perform incremental intervallic test on cycleergometer or treadmill.
  • \- Incapacitating pain that prevents assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anterior Cruciate Ligament InjuriesMotor Activity

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and InjuriesBehavior

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Francesc Valenzuela-Pascual, PhD

    Universitat de Lleida

    STUDY DIRECTOR
  • Oriol Martínez-Navarro, PhD

    Universitat de Lleida

    STUDY DIRECTOR

Central Study Contacts

Francisco J. Verdejo-Amengual

CONTACT

Oriol Martínez-Navarro, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student and Associate Professor

Study Record Dates

First Submitted

September 25, 2024

First Posted

October 1, 2024

Study Start

December 2, 2024

Primary Completion

November 30, 2025

Study Completion (Estimated)

December 2, 2026

Last Updated

October 1, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share
Shared Documents
SAP, ICF